Jefferies Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-45,000
Closed -$2.5M 1995
2025
Q3
$2.5M Buy
+45,000
New +$2.63M 0.01% 567
2024
Q4
Sell
-10,800
Closed -$1.29M 1762
2024
Q3
$1.29M Buy
+10,800
New +$1.44M 0.01% 716
2024
Q2
Sell
-10,000
Closed -$1.28M 1749
2024
Q1
$1.28M Buy
+10,000
New +$1.19M 0.01% 732

Other funds holding NVO

Jefferies Financial Group's NVO Position: Q1 2026 in Review

Jefferies Financial Group increased its Novo Nordisk (NVO) stake by 682% in Q1 2026, buying an estimated $683K and bringing the position to 16,524 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Jefferies Financial Group first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.29M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Jefferies Financial Group held 16,524 shares of Novo Nordisk worth $607K as of Q1 2026.
  • Jefferies Financial Group bought 14,412 Novo Nordisk shares in Q1 2026, an estimated $683K.
  • Novo Nordisk made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1127 holding.
  • Jefferies Financial Group first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Novo Nordisk position peaked at $2.29M in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.